Inside Precision Medicine Marketplace Molecular Diagnostics QIAseq Targeted Methyl Panels

QIAGEN
QIAseq Targeted Methyl Panels

A liquid biopsy-compatible solution for targeting methylation status of DNA, from as low as 1 ng input DNA from cells and tissues, or 10 ng from FFPE samples and liquid biopsies.

QIAseq Targeted Methyl Panels offer a single-day solution capable of targeting thousands of CpG sites in the genome. As with targeted DNA panels, QIAseq solutions are based on single-primer extension (SPE) technology that provides a sensitive and specific solution for detecting regions all across the genome.




QIAGEN

19300 Germantown Road
Germantown, MD 20874
800-426-8157
https://www.qiagen.com





Features & Specs

  • Complete system to go from bisulfite-converted DNA to a sequencing-ready library using a single-day workflow
  • Error correction with Unique Molecular Indices (UMIs) to enhance NGS panel sensitivity
  • A single-primer extension (SPE) approach that increases sensitivity and overcomes targeting challenges compared to other NGS technologies
  • Integrated Sample to Insight analysis solutions with cloud-based QIAGEN GeneGlobe or locally-installed QIAGEN CLC Genomics Workbench software

Features & Specs

  • Complete system to go from bisulfite-converted DNA to a sequencing-ready library using a single-day workflow
  • Error correction with Unique Molecular Indices (UMIs) to enhance NGS panel sensitivity
  • A single-primer extension (SPE) approach that increases sensitivity and overcomes targeting challenges compared to other NGS technologies
  • Integrated Sample to Insight analysis solutions with cloud-based QIAGEN GeneGlobe or locally-installed QIAGEN CLC Genomics Workbench software